• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tie2,一种来自新型细胞表面受体的假定蛋白酪氨酸激酶。

tie2, a putative protein tyrosine kinase from a new class of cell surface receptor.

作者信息

Runting A S, Stacker S A, Wilks A F

机构信息

Ludwig Institute for Cancer Research, Post Office Royal Melbourne Hospital, Parkville, Victoria, Australia.

出版信息

Growth Factors. 1993;9(2):99-105.

PMID:8217221
Abstract

The cDNA of a novel mouse cell surface receptor (tie2) has been isolated from a mouse lung library. The predicted amino acid sequence of tie2 encodes a protein of 1122 amino acids, with an extracellular domain and an intracellular tyrosine kinase domain bisected by a transmembrane region. The extracellular domain consists of two Ig-like domains, three cysteine-rich domains and three fibronectin type III repeats whilst the intracellular tyrosine kinase domain has a short insert region of 15 amino acids. In vitro transcription/translation of the tie2 cDNA demonstrates that it encodes a glycoprotein of some 145 kDa. The tie2 protein exhibits a high degree of similarity to the cell surface receptor tie, (Partanen, J. et al., (1992) Mol. Cell. Biol., 12, 1698-1707), and together with this protein defines a new class of cell surface receptor.

摘要

一种新型小鼠细胞表面受体(tie2)的互补DNA(cDNA)已从小鼠肺文库中分离出来。tie2预测的氨基酸序列编码一个由1122个氨基酸组成的蛋白质,其细胞外结构域和细胞内酪氨酸激酶结构域被一个跨膜区域一分为二。细胞外结构域由两个免疫球蛋白(Ig)样结构域、三个富含半胱氨酸的结构域和三个纤连蛋白III型重复序列组成,而细胞内酪氨酸激酶结构域有一个由15个氨基酸组成的短插入区域。tie2 cDNA的体外转录/翻译表明它编码一种约145 kDa的糖蛋白。tie2蛋白与细胞表面受体tie表现出高度相似性(帕尔塔宁,J.等人,(1992年)《分子与细胞生物学》,12卷,1698 - 1707页),并且与该蛋白共同定义了一类新的细胞表面受体。

相似文献

1
tie2, a putative protein tyrosine kinase from a new class of cell surface receptor.Tie2,一种来自新型细胞表面受体的假定蛋白酪氨酸激酶。
Growth Factors. 1993;9(2):99-105.
2
Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family.具有相关表达谱的不同大鼠基因定义了一个TIE受体酪氨酸激酶家族。
Oncogene. 1993 Jun;8(6):1631-7.
3
Molecular cloning and chromosomal localization of the mouse Gpr37 gene encoding an orphan G-protein-coupled peptide receptor expressed in brain and testis.编码在脑和睾丸中表达的孤儿G蛋白偶联肽受体的小鼠Gpr37基因的分子克隆及染色体定位。
Genomics. 1998 Nov 1;53(3):315-24. doi: 10.1006/geno.1998.5433.
4
Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor.一类新型人类免疫球蛋白超家族成员的分子鉴定,该家族成员具有基于免疫受体酪氨酸的抑制基序,且与小鼠gp49B1抑制性受体具有同源性。
J Immunol. 1997 Sep 1;159(5):2342-9.
5
Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta.人胎盘来源新型受体蛋白酪氨酸激酶的分子克隆与特性分析
Oncogene. 1993 Mar;8(3):663-70.
6
Cloning and characterization of SCART1, a novel scavenger receptor cysteine-rich type I transmembrane molecule.新型I型富含半胱氨酸的清道夫受体跨膜分子SCART1的克隆与特性分析
Mol Immunol. 2009 May;46(8-9):1663-72. doi: 10.1016/j.molimm.2009.02.016. Epub 2009 Mar 17.
7
Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.一种与fms家族密切相关的新型人类受体型酪氨酸激酶基因(flt)的核苷酸序列及表达
Oncogene. 1990 Apr;5(4):519-24.
8
A new member of the Eph family of receptors that lacks protein tyrosine kinase activity.Eph受体家族的一个新成员,缺乏蛋白酪氨酸激酶活性。
Oncogene. 1996 Aug 15;13(4):777-86.
9
Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells.小鼠TIE和TEK受体酪氨酸激酶基因的分子克隆、特性分析及其在造血干细胞中的表达
Biochem Biophys Res Commun. 1993 Aug 31;195(1):301-9. doi: 10.1006/bbrc.1993.2045.
10
FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines.
Cancer Res. 1992 Oct 15;52(20):5738-43.

引用本文的文献

1
Beyond VEGF: Angiopoietin-Tie Signaling Pathway in Diabetic Retinopathy.超越血管内皮生长因子:糖尿病视网膜病变中的血管生成素-Tie信号通路
J Clin Med. 2024 May 9;13(10):2778. doi: 10.3390/jcm13102778.
2
Dynamic modeling of folliculogenesis signaling pathways in the presence of miRNAs expression.miRNAs 表达存在下的卵泡发生信号通路的动态建模。
J Ovarian Res. 2017 Dec 19;10(1):76. doi: 10.1186/s13048-017-0371-y.
3
Regulation of Angiopoietin Signalling by Soluble Tie2 Ectodomain and Engineered Ligand Trap.可溶性 Tie2 胞外域和工程化配体陷阱对血管生成素信号的调节。
Sci Rep. 2017 Jun 16;7(1):3658. doi: 10.1038/s41598-017-03981-6.
4
The molecular balance between receptor tyrosine kinases Tie1 and Tie2 is dynamically controlled by VEGF and TNFα and regulates angiopoietin signalling.受体酪氨酸激酶 Tie1 和 Tie2 之间的分子平衡受 VEGF 和 TNFα 的动态调控,并调节血管生成素信号通路。
PLoS One. 2012;7(1):e29319. doi: 10.1371/journal.pone.0029319. Epub 2012 Jan 3.
5
Transcriptional targeting of tumor endothelial cells for gene therapy.用于基因治疗的肿瘤内皮细胞的转录靶向
Adv Drug Deliv Rev. 2009 Jul 2;61(7-8):542-53. doi: 10.1016/j.addr.2009.02.006. Epub 2009 Apr 23.
6
The opening act: vasculogenesis and the origins of circulation.开场:血管生成与循环系统的起源
Arterioscler Thromb Vasc Biol. 2009 May;29(5):623-9. doi: 10.1161/ATVBAHA.107.161539. Epub 2008 Nov 13.
7
An entirely cell-based system to generate single-chain antibodies against cell surface receptors.一种完全基于细胞的系统,用于生成针对细胞表面受体的单链抗体。
J Mol Biol. 2008 May 30;379(2):261-72. doi: 10.1016/j.jmb.2008.03.072. Epub 2008 Apr 7.
8
Intra and extravascular transmembrane signalling of angiopoietin-1-Tie2 receptor in health and disease.血管生成素-1-Tie2受体在健康与疾病中的血管内和血管外跨膜信号传导
J Cell Mol Med. 2008 Jun;12(3):810-28. doi: 10.1111/j.1582-4934.2008.00254.x. Epub 2008 Feb 4.
9
Signaling and functions of angiopoietin-1 in vascular protection.血管生成素-1在血管保护中的信号传导与功能
Circ Res. 2006 Apr 28;98(8):1014-23. doi: 10.1161/01.RES.0000218275.54089.12.
10
Expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: implication for angiogenesis.血管生成素1、2及其共同受体Tie2在人胃癌中的表达:对血管生成的影响
J Korean Med Sci. 2006 Apr;21(2):272-8. doi: 10.3346/jkms.2006.21.2.272.